# FDA Inspection 1165934 - OneBlood Inc - March 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/34fa2bd4-dd3c-455c-985a-6f6db4178747
Source feed: FDA_Inspections

> FDA Inspection 1165934 for OneBlood Inc on March 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165934
- Company Name: OneBlood Inc
- Inspection Date: 2022-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1165934 - 2022-03-17](https://www.keypedia.com/records/fda_inspections/oneblood-inc/3a0cd0c9-4689-4551-81c9-187973d950f0)

Company: https://www.keypedia.com/companies/oneblood-inc/e6911617-62c2-4bfd-8d01-a46c06273ae9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d